FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Paclitaxel is used to treat breast cancers, but the mechanisms by which it induces apoptosis are poorly understood. Consequently, we have studied the role of the FoxO transcription factors in determining cellular response to paclitaxel. Western blotting revealed that in a panel of nine breast cancer cell lines expression of FoxO1a and FoxO3a correlated with the expression of the pro-apoptotic FoxO target Bim, which was associated with paclitaxel-induced apoptosis. In MCF-7 cells, which were paclitaxel-sensitive, the already high basal levels of FoxO3a and Bim protein increased dramatically after drug treatment, as did Bim mRNA, which correlated with apoptosis induction. This was not observed in MDA-231 cells, which expressed low levels of FoxOs and Bim. Gene reporter experiments demonstrated that in MCF-7 cells maximal induction of Bim promoter was dependent on a FoxO binding site, suggesting that FoxO3a is responsible for the transcriptional up-regulation of Bim. Gene silencing experiments showed that small interference RNA (siRNA) specific for FoxO3a reduced the levels of FoxO3a and Bim protein as well as inhibited apoptosis in paclitaxel-treated MCF-7 cells. Furthermore, siRNA specific for Bim reduced the levels of Bim protein and inhibited apoptosis in paclitaxel-treated MCF-7 cells. This is the first demonstration that up-regulation of FoxO3a by paclitaxel can result in increased levels of Bim mRNA and protein, which can be a direct cause of apoptosis in breast cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The suppression of the AKT pathway activates downstream FoxO3a, resulting in the restoration of Bim transcriptional induction by FoxO3a [45, 46].”
Citations
Cites
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Self-citationBouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Self-citationBiggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
Dijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976
Self-citationPhosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Research works printed but not linked: 3
- Page, 2000, Int. J. Oncol., 17, 23
- Tanabe, 2003, Int. J. Oncol., 22, 875
- Clark, 2002, Mol. Cancer Ther., 1, 707
Cited by
Items 201–300 of 540
Yang, Y., Tang, Y.-A., Shieh, J.-M., Lin, R.-K., Hsu, H., & Wang, Y. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000240 · Cited by 55
PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol
Szántó, Á., Hellebrand, E., Bognár, Z., Tucsek, Z., Szabó, A., Gallyas, F., Sümegi, B., & Várbiró, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.008 · Cited by 55
Campone, M., Noël, B., Couriaud, C., Grau, M., Guillemin, Y., Gautier, F., Gouraud, W., Guérin‐Charbonnel, C., Campion, L., Jézéquel, P., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-110 · Cited by 55
Kajihara, T., Uchino, S., Suzuki, M., Itakura, A., Brosens, J. J., & Ishihara, O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.05.048 · Cited by 55
Self-citationBumpus, N. N. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.09.008 · Cited by 55
Lee, J., Bartholomeusz, C., Mansour, O. C., Humphries, J., Hortobágyi, G. N., Ordentlich, P., & Ueno, N. T. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3014-7 · Cited by 54
Howie, H. L., Shiflett, S. L., & So, M. (2008) · Infection and Immunity · doi:10.1128/iai.00153-08 · Cited by 54
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
Blanchard, Z., Paul, B. T., Craft, B. S., & ElShamy, W. M. (2015) · Breast Cancer Research · doi:10.1186/s13058-014-0512-9 · Cited by 53
MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix
Nho, R. S., Im, J., Ho, Y.-Y., & Hergert, P. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00127.2014 · Cited by 53
Shi, X.-Y., Ding, W., Li, T., Zhang, Y., & Zhao, S. (2017) · Medical Science Monitor · doi:10.12659/msm.904597 · Cited by 53
FOXO Transcription Factors: From Cell Fate Decisions to Regulation of Human Female Reproduction
Brosens, J. J., Wilson, M., & Lam, E. W. ‐. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_17 · Cited by 53
Self-citationForkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer
de Moraes, G. N., Khongkow, P., Gong, C., Yao, S. J., Gomes, A., Ji, Z., Kandola, N. K., Delbue, D., Man, E. P. S., Khoo, U., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.26 · Cited by 52
Self-citationEmerging targets in cancer drug resistance
Kumar, S., Kushwaha, P. P., & Gupta, S. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2018.27 · Cited by 52
Hu, T. X., Chung, Y. M., Guan, M., Ma, M., Ma, J., Berek, J. S., & Hu, M. C. ‐. (2014) · Scientific Reports · doi:10.1038/srep05810 · Cited by 52
Fei, M., Lu, M., Wang, Y., Zhao, Y., He, S., Gao, S., Ke, Q., Liu, Y., Li, P., Cui, X., et al. (2008) · Medical Oncology · doi:10.1007/s12032-008-9105-8 · Cited by 52
Forkhead box-O transcription factor: critical conductors of cancer's fate
Weidinger, C., Krause, K., Klagge, A., Karger, S., & Führer, D. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0153 · Cited by 51
Fang, C., Xu, H., Yuan, L., Zhu, Z., Wang, X., Liu, Y., Zhang, A., Shao, A., & Lou, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1949718 · Cited by 51
In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells
Franco-Molina, M. Á., Mendoza-Gamboa, E., Miranda-Hernández, D. F., Zapata‐Benavides, P., Castillo-León, L., Isaza-Brando, C. E., Taméz-Guerra, R. S., & Rodríguez-Padilla, C. (2006) · Cytotherapy · doi:10.1080/14653240600847266 · Cited by 51
Park, E., Woo, S. M., Min, K., & Kwon, T. K. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12102 · Cited by 50
Negative Feedback Loop in the Bim–Caspase-3 Axis Regulating Apoptosis and Activity of Osteoclasts
Wakeyama, H., Akiyama, T., Takahashi, K., Amano, H., Kadono, Y., Nakamura, M., Oshima, Y., Itabe, H., Nakayama, K. I., Nakayama, K., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070619 · Cited by 50
PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2+ breast cancer cells by inducing Bim
Park, S. H., Ito, K., Olcott, W., Katsyv, I., Halstead-Nussloch, G., & Irie, H. Y. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0594-z · Cited by 50
FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization
Su, J.-L., Cheng, X., Yamaguchi, H., Chang, Y.-W., Hou, C.-F., Lee, D., Ko, H., Hua, K., Wang, Y., Hsiao, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0295 · Cited by 50
Ji, H., Tian, D., Zhang, B., Zhang, Y., Yan, D., & Wu, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4263 · Cited by 50
Fukazawa, H., Noguchi, K., Masumi, A., Murakami, Y., & Uehara, Y. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1281.3.10 · Cited by 49
Kajihara, T., Tochigi, H., Prechapanich, J., Uchino, S., Itakura, A., Brosens, J. J., & Ishihara, O. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.017 · Cited by 49
Self-citationLung Ischemia: A Model for Endothelial Mechanotransduction
Chatterjee, S., Chapman, K. E., & Fisher, A. B. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9030-7 · Cited by 49
Zhang, G., He, P., Gaedcke, J., Ghadimi, Β. M., Ried, T., Yfantis, H. G., Lee, D. H., Hanna, N. N., Alexander, H. R., & Hussain, S. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0362 · Cited by 49
c-Jun N-terminal kinase – c-Jun pathway transactivates Bim to promote osteoarthritis
Ye, Z., Chen, Y., Zhang, R., Dai, H., Zeng, C., Zeng, H., Feng, H., Du, G., Fang, H., & Cai, D. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0228 · Cited by 48
Rosich, L., Saborit-Villarroya, I., Lopez-Guerra, M., Xargay‐Torrent, S., Montraveta, A., Aymerich, M., Villamor, N., Campo, E., Pérez‐Galán, P., Roué, G., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.088849 · Cited by 48
Savry, A., Carre, M., Bergès, R., Rovini, A. M. F., Pobel, I., Chacon, C., Braguer, D., & Bourgarel‐Rey, V. (2013) · Neoplasia · doi:10.1593/neo.121074 · Cited by 48
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma
Hersey, P. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000208794.24228.9f · Cited by 48
Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a
Lee, N., Pun, N. T., Jang, W., Bae, J. W., & Jeong, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15389 · Cited by 47
MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a
Li, Y., Li, A., Wu, J., He, Y., Yu, H., Chai, R., & Li, H. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.246 · Cited by 46
“FOXO3a is a proapoptotic transcription factor that functions by activating BIM, a pro-apoptotic member of the BCL-2 protein family.(60,61) BIM activates Bax to induce mitochondrialdependent apoptosis.”
BackgroundDeubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach
Ma, Z., Zhou, M., Chen, H., Shen, Q., & Zhou, J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02975 · Cited by 45
Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression
Zhou, Y., Farooqi, A. A., & Xu, B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2000933 · Cited by 45
ER stress and cancer: The FOXO forkhead transcription factor link
Alasiri, G. A., Fan, L. Y.-N., Zona, S., Goldsbrough, I., Ke, H.-L., Auner, H. W., & Lam, E. W. ‐. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.027 · Cited by 45
Self-citationThe tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival
Obrador‐Hevia, A., Serra‐Sitjar, M., Rodríguez, J., Villalonga, P., & de Mattos, S. F. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08951.x · Cited by 45
Zhu, X., Wang, K., Zhang, K., Huang, B., Zhang, J., Zhang, Y., Zhu, L., Zhou, B., & Zhou, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918041 · Cited by 44
Liu, Z., Shi, Z., Lin, J. E., Zhao, S., Hao, M., Xu, J., Li, Y., Zhao, Q., Tao, L., & Diao, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.012 · Cited by 44
Duan, J., Cui, J., Zheng, H., Xi, M., Guo, C., Weng, Y., Yin, Y., Wei, G., Cao, J., Wang, Y., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7609765 · Cited by 43
Ciechomska, I. A., Gielniewski, B., Wojtaś, B., Kaminska, B., & Mieczkowski, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0479-9 · Cited by 43
MK-STYX, a Catalytically Inactive Phosphatase Regulating Mitochondrially Dependent Apoptosis
Niemi, N. M., Lanning, N. J., Klomp, J. A., Tait, S. W. G., Xu, Y., Dykema, K. J., Murphy, L. O., Gaither, L. A., Xu, H. E., Furge, K. A., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00788-10 · Cited by 42
Thomadaki, H., & Scorilas, A. (2008) · Connective Tissue Research · doi:10.1080/03008200802147829 · Cited by 42
Morris, J. B., Kenney, B., Huynh, H., & Woodcock, E. A. (2005) · Endocrinology · doi:10.1210/en.2005-0162 · Cited by 42
Ahmad, J. N., Černý, O., Linhartová, I., Mašín, J., Osička, R., & Šebo, P. (2015) · Cellular Microbiology · doi:10.1111/cmi.12519 · Cited by 40
Wang, P., Gilmore, A. P., & Streuli, C. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400248200 · Cited by 40
Timilsina, S., Rajamanickam, S., Rao, A., Subbarayalu, P., Nirzhor, S. S. R., Abdelfattah, N., Viswanadhapalli, S., Chen, Y., Jatoi, I., Brenner, A. J., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215717 · Cited by 40
Alasiri, G. A., Jiramongkol, Y., Trakansuebkul, S., Ke, H.-L., Mahmud, Z., Intuyod, K., & Lam, E. W. ‐. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110932 · Cited by 40
Self-citationMechanisms controlling the anti-neoplastic functions of FoxO proteins
Hou, T., Li, Z., Zhao, Y., & Zhu, W. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.007 · Cited by 40
Zañudo, J. G. T., Mao, P., Alcon, C., Kowalski, K. J., Johnson, G. N., Xu, G., Baselga, J. M., Scaltriti, M., Letai, A. G., Montero, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1208 · Cited by 39
PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim
Byerly, J. H., Port, E. R., & Irie, H. Y. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01302-w · Cited by 39
Zhou, R., Lu, Z., Liu, K., Guo, J., Liu, J., Zhou, Y., Yang, J., Mi, M., & Xu, H. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009614666141128104642 · Cited by 39
Protease-Activated Receptor-1 (hPar1), A Survival Factor Eliciting Tumor Progression
Salah, Z., Maoz, M., Pokroy, E., Lotem, M., Bar‐Shavit, R., & Uziely, B. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0261 · Cited by 38
Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells.
Szántó, Á., Bognár, Z., Szigeti, A., Szabó, A., Farkas, L., & Gallyas, F. (2009) · PubMed · Cited by 38
Lee, C. M., Lee, J., Nam, M. J., Choi, Y. S., & Park, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061508 · Cited by 38
Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells
Piñeiro, D., Martín, M. E., Guerra‐Pérez, N., Salinas, M., & González, V. M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.020 · Cited by 38
The F‐box protein FBXL 18 promotes glioma progression by promoting K63‐linked ubiquitination of Akt
Zhang, J., Yang, Z., Ou, J., Xia, X., Zhi, F., & Cui, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12521 · Cited by 38
Ock, C. W., & Kim, G. D. (2021) · Molecules · doi:10.3390/molecules26216714 · Cited by 37
Proteasome inhibitor MG132 induces apoptosis in human osteosarcoma U2OS cells
Lee, H. K., Park, S., & Nam, M. J. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211017972 · Cited by 37
Zhang, X., Dong, J., Cai, T., Shen, X., Zhou, X., & Liao, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15491 · Cited by 37
Rehman, A., Kim, Y.-S., Kim, H., Sim, J., Ahn, H., Chung, M. S., Shin, S., & Jang, K. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205052 · Cited by 37
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML
Vachhani, P. J., Bose, P., Rahmani, M., & Grant, S. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00173.2013 · Cited by 36
Intrinsic Role of FoxO3a in the Development of CD8+ T Cell Memory
Tzelepis, F., Joseph, J., Haddad, E. K., MacLean, S., Dudani, R., Agenès, F., Peng, S. L., Sékaly, R., & Sad, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200639 · Cited by 36
The BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism
Craik, A. C., Veldhoen, R. A., Czernick, M., Buckland, T. W., Kyselytzia, K., Ghosh, S., Lai, R. L., Damaraju, S., Underhill, D. A., Mackey, J. R., et al. (2010) · Oncogene · doi:10.1038/onc.2010.272 · Cited by 35
Erythropoietin regulates signaling pathways associated with neuroprotective events
Cornelio-Martínez, S., & Castañeda‐Arellano, R. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06331-9 · Cited by 35
Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
Yu, S., Yu, Y., Sun, Y., Wang, X., Luo, R., Zhao, N., Zhang, W., Li, Q., Cui, Y., Wang, Y., et al. (2015) · PubMed Central · Cited by 35
The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma
Wang, W., He, S., Ji, J., Huang, J., Zhang, S., & Zhang, Y. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2013.03.005 · Cited by 35
Fu, Y., Watts, R. N., Zhang, X. D., Borrow, J. M., & Hersey, P. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000231484.17063.9a · Cited by 35
Targeting the Regulatory Machinery of BIM for Cancer Therapy
Harada, H., & Grant, S. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i2.40 · Cited by 34
Schneiders, U. M., Schyschka, L., Rudy, A., & Vollmar, A. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1179 · Cited by 34
Bonezzi, K., Belotti, D., North, B. J., Ghilardi, C., Borsotti, P., Resovi, A., Ubezio, P., Riva, A., Giavazzi, R., Verdin, E. M., et al. (2012) · Neoplasia · doi:10.1593/neo.12728 · Cited by 34
Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells
Paquet, C., Schmitt, E., Beauchemin, M., & Bertrand, R. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045791.55282.91 · Cited by 34
Qi, W., Weber, C. R., Wasland, K., Roy, H. K., Wali, R. K., Joshi, S., & Savkovic, S. D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00416.2010 · Cited by 34
Xiong, H., Wang, J., Guan, H., Wu, J., Xu, R., WANG, M., Xia, R., Huang, K., Huang, J., Liao, Q., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3391 · Cited by 34
Haque, A., Rahman, M. A., Chen, Z. G., Saba, N. F., Khuri, F. R., Shin, D. M., & Amin, A. R. M. R. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1126-0 · Cited by 34
FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells
Liu, H., Yin, J., Wang, C., Gu, Y., Deng, M., & He, Z. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000117 · Cited by 33
FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL
Consolaro, F., Ghaem‐Maghami, S., Bortolozzi, R., Zona, S., Khongkow, M., Basso, G., Viola, G., & Lam, E. W. ‐. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0127 · Cited by 33
Self-citationRole and regulation of FOXO3a: new insights into breast cancer therapy
Mei, W., Mei, B., Chang, J., Liu, Y., Zhou, Y., Zhu, N., & Hu, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1346745 · Cited by 32
Yamaguchi, H., Chen, C.-T., Chou, C.-K., Pal, A., BORNMANN, W. G., Hortobágyi, G. N., & Hung, M. (2010) · Oncogene · doi:10.1038/onc.2010.295 · Cited by 32
Zhai, Y., Lü, Q., Liu, Y., Cheng, Q., Wei, Y., Zhang, F., Li, C., & Yin, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.207 · Cited by 32
Wang, S., Wang, N., Yu, B., Cao, M., Wang, Y., Guo, Y., Zhang, Y., Zhang, P., Yu, X., Wang, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0880-9 · Cited by 31
Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer
Ma, L., Yan, Y., Bai, Y., Yang, Y., Pan, Y., Gang, X., Karnes, R. J., Zhang, J., Lv, Q., Wu, Q., et al. (2019) · Theranostics · doi:10.7150/thno.34700 · Cited by 31
Blake, D. C., Mikse, O. R., Freeman, W. M., & Herzog, C. R. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.013 · Cited by 31
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
Song, K., Woo, S. R., Chung, J., Lee, H., Oh, S. J., Hong, S.-O., Shim, J., Kim, Y. N., Rho, S. B., Hong, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.462 · Cited by 31
Liu, J., Mu, C., Yue, W., Li, J., Ma, B., Zhao, L., Liu, L., Chen, Q., Chen, Y., Liu, H., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.038 · Cited by 30
Ting, A. Y., & Zelinski, M. B. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox034 · Cited by 30
Long, J., Yang, C., He, J., Liu, X., Ding, Y., Chen, X., Tong, C., Peng, C. X., Wang, Y., & Gao, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27167 · Cited by 29
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
de Moraes, G. N., Ji, Z., Fan, L. Y.-N., Yao, S. J., Zona, S., Sharrocks, A. D., & Lam, E. W. ‐. (2018) · Oncogenesis · doi:10.1038/s41389-018-0038-6 · Cited by 29
Self-citationEffect of estrogen and inhibition of phosphatidylinositol-3 kinase on Akt and FOXO1 in rat uterus
Lengyel, F., Vértes, Z., Kovács, K. A., Környei, J., Sümegi, B., & Vértes, M. (2007) · Steroids · doi:10.1016/j.steroids.2007.03.001 · Cited by 29
Yu, S., Lee, C., Ha, S., Lee, J., Jang, K. Y., & Park, S. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120943935 · Cited by 28
Pandya, V., Glubrecht, D. D., Vos, L. J., Hanson, J., Damaraju, S., Mackey, J. R., Hugh, J. C., & Goping, I. S. (2016) · Oncotarget · doi:10.18632/oncotarget.8924 · Cited by 28
Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1
Berry, E., Hardt, J. L., Clardy, J., Lurain, J. R., & Kim, J. J. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.10.017 · Cited by 27
Transcriptional Role of FOXO1 in Drug Resistance through Antioxidant Defense Systems
Gotō, T., & Takano, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_13 · Cited by 27
Fhearraigh, S. M., & Gee, M. M. M. (2011) · Cell Cycle · doi:10.4161/cc.10.22.18020 · Cited by 27
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Zanella, F., & Carnero, A. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0420-0 · Cited by 27
Kong, W. W., He, L., Coppola, M., Guo, J., Esposito, N. N., Coppola, D., & Cheng, J. Q. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a110.101055 · Cited by 27
LIU, L.-P., Cao, X., Liu, F., Quan, M., Sheng, X.-F., & Ren, K. (2014) · Oncology Letters · doi:10.3892/ol.2014.1911 · Cited by 27
Hernández‐Vargas, H., von Kobbe, C., Sánchez‐Estévez, C., Tendero, M. J., Palacios, J., & Moreno‐Bueno, G. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4821 · Cited by 27
Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1
Vivar, R., Humeres, C., Anfossi, R., Bolivar, S., Catalán, M., Hill, J., Lavandero, S., & Diaz-Araya, G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118695 · Cited by 26
mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
Moss, N. D., & Sussel, L. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00983 · Cited by 26
Metadata
- Authors
- Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F.
- Affiliations
- Cancer Research UK (GB)
- The Netherlands Cancer Institute (NL)
- Hammersmith Hospital (GB)
- University Medical Center Utrecht (NL)
- Corresponding author
- Lam, Eric W.-F.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 50
- Pages
- 49795-49805
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1422650632
- Cited by
- 505
- References
- 52
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 19 · 2022: 9 · 2021: 14 · 2020: 22 · 2019: 27 · 2018: 16 · 2017: 24 · 2016: 10 · 2015: 27 · 2014: 34 · 2013: 39 · 2012: 32
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6139 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- FOXO3, building information modeling, apoptosis, paclitaxel, breast cancer, FOXO transcription factors, transcriptional regulation, MCF-7 cells, MDA-MB-231 cells, drug resistance, siRNA knockdown
- MeSH terms
- Forkhead Box Protein O1, Bcl-2-Like Protein 11, Antineoplastic Agents, Phytogenic, Binding Sites, Breast Neoplasms, Carrier Proteins, Cell Line, DNA-Binding Proteins, Humans, Membrane Proteins, Mitosis, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Blotting, Western, Up-Regulation, Gene Expression Regulation, Neoplastic, G2 Phase, Apoptosis, Paclitaxel, Annexin A5, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Cell Line, Tumor, Apoptosis Regulatory Proteins, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.